Recent advances in understanding the molecular basis of polymorphisms in genes encoding cytochrome P450 enzymes
- 1 December 1998
- journal article
- review article
- Published by Elsevier in Toxicology Letters
- Vol. 102-103, 143-147
- https://doi.org/10.1016/s0378-4274(98)00299-9
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Detection and characterization of novel polymorphisms in the CYP2E1 genePharmacogenetics, 1998
- [22] CYP2D6 multiallelismPublished by Elsevier ,1996
- Molecular basis of polymorphic drug metabolismJournal of Molecular Medicine, 1995
- Genetic polymorphism of induction of CYP1A1 (EROD) activityPharmacogenetics, 1995
- Pharmacogenetic Phenotyping and GenotypingClinical Pharmacokinetics, 1994
- Metabolic cytochrome P450 genotypes and assessment of individual susceptibility to lung cancerPharmacogenetics, 1992
- High Susceptibility to Lung Cancer Analyzed in Terms of Combined Genotypes of P450IA1 and Mu‐class Glutathione S‐Transferase GenesJapanese Journal of Cancer Research, 1992
- Genetic Polymorphisms in the 5′-Flanking Region Change Transcriptional Regulation of the Human Cytochrome P450IIE1 Gene1The Journal of Biochemistry, 1991
- Lung Cancer and the Debrisoquine Metabolic PhenotypeJNCI Journal of the National Cancer Institute, 1990
- Metabolic oxidation phenotypes as markers for susceptibility to lung cancerNature, 1984